Stock BIO BIOME GROW INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biome Grow Inc.

Equities

BIO

CA09075M1023

Pharmaceuticals

Delayed Canadian Securities Exchange
Other stock markets
 01:21:54 03/05/2024 am IST 		5-day change 1st Jan Change
0.005 CAD 0.00% Intraday chart for Biome Grow Inc. 0.00% 0.00%
2023 Biome Grow Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Biome Grow Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 75.91 17.72 5.059 3.935 1.124
Enterprise Value (EV) 1 74.05 19.06 -2.487 -1.972 4.947
P/E ratio -7.96 x -1.87 x -21.1 x -28.1 x -0.1 x
Yield - - - - -
Capitalization / Revenue - 37,86,087 x - - -
EV / Revenue - 40,73,918 x - - -
EV / EBITDA -1,56,78,245 x -49,26,815 x 6,12,865 x - -
EV / FCF -3,14,26,974 x -58,71,979 x 15,59,403 x 24,33,729 x 1,00,66,649 x
FCF Yield -0% -0% 0% 0% 0%
Price to Book 5.06 x 2.58 x 0.78 x 0.61 x -0.25 x
Nbr of stocks (in thousands) 1,10,014 1,10,720 1,12,417 1,12,417 1,12,417
Reference price 2 0.6900 0.1600 0.0450 0.0350 0.0100
Announcement Date 30/04/19 29/04/20 30/04/21 29/04/22 01/05/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - 4.679 - - -
EBITDA - -4.723 -3.869 -4.058 - -
EBIT 1 -0.792 -4.983 -4.169 -4.173 -1.01 -0.6097
Operating Margin - - -89.11% - - -
Earnings before Tax (EBT) 1 -0.8276 -8.862 -9.746 -1.717 -0.1399 -10.89
Net income 1 -0.8276 -8.862 -9.481 -0.2392 -0.1399 -10.89
Net margin - - -202.62% - - -
EPS 2 -0.0800 -0.0867 -0.0857 -0.002137 -0.001244 -0.0968
Free Cash Flow - -2.356 -3.246 -1.595 -0.8102 0.4914
FCF margin - - -69.38% - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 01/06/18 30/04/19 29/04/20 30/04/21 29/04/22 01/05/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 1.35 - - 3.82
Net Cash position 1 3.07 1.86 - 7.55 5.91 -
Leverage (Debt/EBITDA) - - -0.3481 x - - -
Free Cash Flow - -2.36 -3.25 -1.59 -0.81 0.49
ROE (net income / shareholders' equity) -16.9% -71.5% -86.5% -25.6% -2.16% -1,085%
ROA (Net income/ Total Assets) - -24.1% -17.7% -19.8% -5.34% -6.61%
Assets 1 - 36.8 53.43 1.206 2.622 164.8
Book Value Per Share 2 0.5200 0.1400 0.0600 0.0600 0.0600 -0.0400
Cash Flow per Share 2 0.1600 0.0200 0.0100 0 0.0100 0
Capex 1 1.62 3.39 1.75 - - -
Capex / Sales - - 37.35% - - -
Announcement Date 01/06/18 30/04/19 29/04/20 30/04/21 29/04/22 01/05/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
BIOME GROW INC. Stock Biome Grow Inc.
0.00% 411K
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+40.09% 6.3B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.34% 4.53B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-7.11% 3.29B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+5.14% 3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.18% 2.63B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.93% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.15% 1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.67% 1.69B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.73% 1.64B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. BIO Stock
  4. Financials Biome Grow Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW